Literature DB >> 21076035

Human T-cell leukemia virus type 1 p8 protein increases cellular conduits and virus transmission.

Nancy Van Prooyen1, Heather Gold, Vibeke Andresen, Owen Schwartz, Kathryn Jones, Frank Ruscetti, Stephen Lockett, Prabhakar Gudla, David Venzon, Genoveffa Franchini.   

Abstract

The human T-cell leukemia virus type 1 (HTLV-1) is the cause of adult T-cell leukemia/lymphoma as well as tropical spastic paraparesis/HTLV-1-associated myelopathy. HTLV-1 is transmitted to T cells through the virological synapse and by extracellular viral assemblies. Here, we uncovered an additional mechanism of virus transmission that is regulated by the HTLV-1-encoded p8 protein. We found that the p8 protein, known to anergize T cells, is also able to increase T-cell contact through lymphocyte function-associated antigen-1 clustering. In addition, p8 augments the number and length of cellular conduits among T cells and is transferred to neighboring T cells through these conduits. p8, by establishing a T-cell network, enhances the envelope-dependent transmission of HTLV-1. Thus, the ability of p8 to simultaneously anergize and cluster T cells, together with its induction of cellular conduits, secures virus propagation while avoiding the host's immune surveillance. This work identifies p8 as a viral target for the development of therapeutic strategies that may limit the expansion of infected cells in HTLV-1 carriers and decrease HTLV-1-associated morbidity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21076035      PMCID: PMC2996430          DOI: 10.1073/pnas.1009635107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

1.  Nanotubular highways for intercellular organelle transport.

Authors:  Amin Rustom; Rainer Saffrich; Ivanka Markovic; Paul Walther; Hans-Hermann Gerdes
Journal:  Science       Date:  2004-02-13       Impact factor: 47.728

2.  Ultrastructural studies of surface features of human normal and tumor cells in tissue culture by scanning and transmission electron microscopy.

Authors:  M A Gonda; S A Aaronson; N Ellmore; V H Zeve; K Nagashima
Journal:  J Natl Cancer Inst       Date:  1976-02       Impact factor: 13.506

3.  The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription.

Authors:  Gilles Gaudray; Frederic Gachon; Jihane Basbous; Martine Biard-Piechaczyk; Christian Devaux; Jean-Michel Mesnard
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

4.  HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication.

Authors:  Christophe Nicot; Miroslav Dundr; Julie M Johnson; Jake R Fullen; Norma Alonzo; Risaku Fukumoto; Gerald L Princler; David Derse; Tom Misteli; Genoveffa Franchini
Journal:  Nat Med       Date:  2004-01-18       Impact factor: 53.440

5.  Clinical course of retrovirus-associated adult T-cell lymphoma in the United States.

Authors:  P A Bunn; G P Schechter; E Jaffe; D Blayney; R C Young; M J Matthews; W Blattner; S Broder; M Robert-Guroff; R C Gallo
Journal:  N Engl J Med       Date:  1983-08-04       Impact factor: 91.245

6.  Transformation of different phenotypic types of human bone marrow T-lymphocytes by HTLV-1.

Authors:  P D Markham; S Z Salahuddin; B Macchi; M Robert-Guroff; R C Gallo
Journal:  Int J Cancer       Date:  1984-01-15       Impact factor: 7.396

7.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

8.  Late assembly motifs of human T-cell leukemia virus type 1 and their relative roles in particle release.

Authors:  Gisela Heidecker; Patricia A Lloyd; Kristi Fox; Kunio Nagashima; David Derse
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

9.  HIV-1 evades virus-specific IgG2 and IgA responses by targeting systemic and intestinal B cells via long-range intercellular conduits.

Authors:  Weifeng Xu; Paul A Santini; John S Sullivan; Bing He; Meimei Shan; Susan C Ball; Wayne B Dyer; Thomas J Ketas; Amy Chadburn; Leona Cohen-Gould; Daniel M Knowles; April Chiu; Rogier W Sanders; Kang Chen; Andrea Cerutti
Journal:  Nat Immunol       Date:  2009-08-02       Impact factor: 25.606

10.  Inhibition of T cell receptor signal transduction by tyrosine kinase-interacting protein of Herpesvirus saimiri.

Authors:  Nam-Hyuk Cho; Pinghui Feng; Sun-Hwa Lee; Bok-Soo Lee; Xiaozhen Liang; Heesoon Chang; Jae U Jung
Journal:  J Exp Med       Date:  2004-08-30       Impact factor: 14.307

View more
  74 in total

Review 1.  Molecular mechanisms of HTLV-1 infection and pathogenesis.

Authors:  Junichiro Yasunaga; Masao Matsuoka
Journal:  Int J Hematol       Date:  2011-09-28       Impact factor: 2.490

Review 2.  Human T-lymphotropic virus proteins and post-translational modification pathways.

Authors:  Carlo Bidoia
Journal:  World J Virol       Date:  2012-08-12

Review 3.  Hijacking the T-cell communication network by the human T-cell leukemia/lymphoma virus type 1 (HTLV-1) p12 and p8 proteins.

Authors:  Nancy Van Prooyen; Vibeke Andresen; Heather Gold; Izabela Bialuk; Cynthia Pise-Masison; Genoveffa Franchini
Journal:  Mol Aspects Med       Date:  2010-07-29

4.  Infection of defective human T-lymphotropic virus type 1.

Authors:  Yuuki Hashikura; Kazumi Umeki; Kunihiko Umekita; Hajime Nomura; Akiteru Yamada; Ikuo Yamamoto; Hiroo Hasegawa; Katsunori Yanagihara; Akihiko Okayama
Journal:  Hum Cell       Date:  2017-01-09       Impact factor: 4.174

Review 5.  Bridging the Gap: Virus Long-Distance Spread via Tunneling Nanotubes.

Authors:  Robert J J Jansens; Alexander Tishchenko; Herman W Favoreel
Journal:  J Virol       Date:  2020-03-31       Impact factor: 5.103

6.  Human T-cell leukemia/lymphoma virus type 1 p30, but not p12/p8, counteracts toll-like receptor 3 (TLR3) and TLR4 signaling in human monocytes and dendritic cells.

Authors:  Claudio Fenizia; Martina Fiocchi; Kathryn Jones; Robyn Washington Parks; Michele Ceribelli; Sebastien A Chevalier; Dustin Edwards; Francis Ruscetti; Cynthia A Pise-Masison; Genoveffa Franchini
Journal:  J Virol       Date:  2013-10-23       Impact factor: 5.103

7.  APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1.

Authors:  Marcel Ooms; Aikaterini Krikoni; Andrea K Kress; Viviana Simon; Carsten Münk
Journal:  J Virol       Date:  2012-03-28       Impact factor: 5.103

8.  Analyses of HTLV-1 sequences suggest interaction between ORF-I mutations and HAM/TSP outcome.

Authors:  Fernanda Khouri Barreto; Ricardo Khouri; Filipe Ferreira de Almeida Rego; Luciane Amorim Santos; Maria Fernanda de Castro-Amarante; Izabela Bialuk; Cynthia A Pise-Masison; Bernardo Galvão-Castro; Antoine Gessain; Steven Jacobson; Genoveffa Franchini; Luiz Carlos Alcantara
Journal:  Infect Genet Evol       Date:  2016-08-21       Impact factor: 3.342

9.  Palmitoylation and p8-mediated human T-cell leukemia virus type 1 transmission.

Authors:  Dustin Edwards; Risaku Fukumoto; Maria Fernanda de Castro-Amarante; Luiz Carlos Junior Alcantara; Bernardo Galvão-Castro; Robyn Washington Parks; Cynthia Pise-Masison; Genoveffa Franchini
Journal:  J Virol       Date:  2013-11-27       Impact factor: 5.103

Review 10.  Molecular mechanisms of viral oncogenesis in humans.

Authors:  Nathan A Krump; Jianxin You
Journal:  Nat Rev Microbiol       Date:  2018-11       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.